FDAFX vs. LTIUX
Compare and contrast key facts about Fidelity Advisor Freedom 2020 Fund Class A (FDAFX) and Principal LifeTime 2035 Fund (LTIUX).
FDAFX is managed by Fidelity. It was launched on Jul 24, 2003. LTIUX is managed by Principal. It was launched on Feb 28, 2008.
Performance
FDAFX vs. LTIUX - Performance Comparison
Loading graphics...
FDAFX vs. LTIUX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
FDAFX Fidelity Advisor Freedom 2020 Fund Class A | -1.61% | 14.28% | 6.79% | 12.08% | -16.22% | 8.40% | 13.09% | 18.40% | -5.05% | 12.05% |
LTIUX Principal LifeTime 2035 Fund | -3.69% | 14.26% | 14.13% | 16.51% | -17.48% | 14.07% | 15.70% | 23.48% | -7.37% | 19.69% |
Returns By Period
In the year-to-date period, FDAFX achieves a -1.61% return, which is significantly higher than LTIUX's -3.69% return. Over the past 10 years, FDAFX has underperformed LTIUX with an annualized return of 6.33%, while LTIUX has yielded a comparatively higher 8.68% annualized return.
FDAFX
- 1D
- 0.16%
- 1M
- -5.42%
- YTD
- -1.61%
- 6M
- 0.11%
- 1Y
- 10.37%
- 3Y*
- 8.64%
- 5Y*
- 3.71%
- 10Y*
- 6.33%
LTIUX
- 1D
- -0.08%
- 1M
- -6.37%
- YTD
- -3.69%
- 6M
- -1.87%
- 1Y
- 9.88%
- 3Y*
- 11.62%
- 5Y*
- 5.83%
- 10Y*
- 8.68%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
FDAFX vs. LTIUX - Expense Ratio Comparison
FDAFX has a 0.83% expense ratio, which is higher than LTIUX's 0.01% expense ratio.
Return for Risk
FDAFX vs. LTIUX — Risk / Return Rank
FDAFX
LTIUX
FDAFX vs. LTIUX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Fidelity Advisor Freedom 2020 Fund Class A (FDAFX) and Principal LifeTime 2035 Fund (LTIUX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| FDAFX | LTIUX | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 1.27 | 0.90 | +0.37 |
Sortino ratioReturn per unit of downside risk | 1.78 | 1.34 | +0.44 |
Omega ratioGain probability vs. loss probability | 1.27 | 1.19 | +0.08 |
Calmar ratioReturn relative to maximum drawdown | 1.63 | 1.06 | +0.58 |
Martin ratioReturn relative to average drawdown | 6.89 | 5.01 | +1.87 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| FDAFX | LTIUX | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.27 | 0.90 | +0.37 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.42 | 0.50 | -0.07 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.70 | 0.70 | 0.00 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.44 | 0.45 | -0.01 |
Correlation
The correlation between FDAFX and LTIUX is 0.96, which is considered to be high. That indicates a strong positive relationship between their price movements. Having highly-correlated positions in a portfolio may signal a lack of diversification, potentially leading to increased risk during market downturns.
Dividends
FDAFX vs. LTIUX - Dividend Comparison
FDAFX's dividend yield for the trailing twelve months is around 7.82%, less than LTIUX's 9.37% yield.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
FDAFX Fidelity Advisor Freedom 2020 Fund Class A | 7.82% | 7.70% | 4.66% | 2.15% | 8.84% | 10.71% | 6.97% | 6.62% | 9.48% | 3.23% | 4.34% | 3.51% |
LTIUX Principal LifeTime 2035 Fund | 9.37% | 9.03% | 9.46% | 4.17% | 7.50% | 7.06% | 5.35% | 7.28% | 7.75% | 5.46% | 4.28% | 5.59% |
Drawdowns
FDAFX vs. LTIUX - Drawdown Comparison
The maximum FDAFX drawdown since its inception was -47.38%, roughly equal to the maximum LTIUX drawdown of -49.65%. Use the drawdown chart below to compare losses from any high point for FDAFX and LTIUX.
Loading graphics...
Drawdown Indicators
| FDAFX | LTIUX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -47.38% | -49.65% | +2.27% |
Max Drawdown (1Y)Largest decline over 1 year | -6.07% | -8.44% | +2.37% |
Max Drawdown (5Y)Largest decline over 5 years | -22.75% | -24.23% | +1.48% |
Max Drawdown (10Y)Largest decline over 10 years | -22.75% | -28.12% | +5.37% |
Current DrawdownCurrent decline from peak | -5.42% | -6.57% | +1.15% |
Average DrawdownAverage peak-to-trough decline | -5.57% | -6.76% | +1.19% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 1.44% | 1.78% | -0.34% |
Volatility
FDAFX vs. LTIUX - Volatility Comparison
The current volatility for Fidelity Advisor Freedom 2020 Fund Class A (FDAFX) is 3.22%, while Principal LifeTime 2035 Fund (LTIUX) has a volatility of 3.74%. This indicates that FDAFX experiences smaller price fluctuations and is considered to be less risky than LTIUX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| FDAFX | LTIUX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 3.22% | 3.74% | -0.52% |
Volatility (6M)Calculated over the trailing 6-month period | 4.99% | 6.37% | -1.38% |
Volatility (1Y)Calculated over the trailing 1-year period | 8.23% | 11.12% | -2.89% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 8.79% | 11.79% | -3.00% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 9.04% | 12.45% | -3.41% |